Patent · US Expired

Sustained releasable parenteral pharmaceutical preparations and method of producing the same

US5628993A · kind A · utility

31Cited by
3References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 24, 1994
Grant dateMay 13, 1997
Priority date
Expiry dateAug 24, 2014

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/0024
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A parenteral pharmaceutical preparation comprises a matrix containing a physiologically active peptide or protein and a polyglycerol diester of a saturated fatty acid, and the matrix is in a solid form at room temperature. The molecular weight of the physiologically active peptide or protein is 2,000 dalton or more. The saturated fatty acid includes fatty acids having about 16 to 30 carbon atoms such as palmitic acid, stearic acid, etc. The matrix may be in a pillar or granular form. The parenteral pharmaceutical preparation can be used as an injectable solid administered subcutaneously or intramuscularly (for example, a pellet or tablet for implantation), a suppository or the like, and can release the physiologically active peptide or protein sustainedly for a prolonged period of one week or more.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.